Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

RATIONALE: The purpose of this study was to investigate the clinical efficacy and safety of a fixed-dose combination of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate-to-very severe chronic obstructive pulmonary disease (COPD). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, Dennis E, Tashkin, Donald P, Kerwin, Edward, Knorr, Barbara A, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276257/
https://www.ncbi.nlm.nih.gov/pubmed/22334769
http://dx.doi.org/10.2147/COPD.S27320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276257/
https://www.ncbi.nlm.nih.gov/pubmed/22334769
http://dx.doi.org/10.2147/COPD.S27320

Ejemplares similares